To the Problem of Comorbidity of HIV Infection and Tuberculosis

Safronenko A. V.
Doctor of Medical Sciences, Assistant Professor, Head, Chair for Pharmacology and Clinical Pharmacology¹
ORCID 0000-0003-4625-6186

Gantsgorn E. V.
MD, PhD, Assistant Professor, Chair for Pharmacology and Clinical Pharmacology¹
ORCID 0000-0003-0627-8372

Chernigovets L. F.
MD, PhD, Assistant Professor, Chair for Epidemiology¹

Sklyanaya E. A.
Deputy Chief Physician for Organizational, Methodological and Preventive Work²

Chotiy V. A.
Student, Faculty of General Medicine¹

1 - Rostov State Medical University, Rostov-on-Don, Russia
2 - State Budgetary Institution of the Rostov Region «Center for the Prevention and Control of AIDS», Rostov-on-Don, Russia

Gantsgorn Elena Vladimirovna; e-mail: gantsgorn@inbox.ru

None declared.

The study had no sponsorship.

The problem of combined HIV infection and TB has a high medico-biological, medico-social and medico-economic significance, which has been steadily growing lately. At the same time, this variant of infectious comorbidity is an interdisciplinary problem of international dimension. This analytical article summarizes both the data presented in the literature and the results of our own research. To improve the current state of this problem, in our opinion, it is extremely important to take measures to increase the alertness of primary care physicians to the possibility of such comorbidity, the level of knowledge in the field of phthisiology, epidemiology, clinical pharmacology, the active use of methods for determining the sensitivity of mycobacteria to anti-tuberculosis therapy, including express molecular genetic analysis, increased patient compliance. Only close cooperation of health professionals and their coordinated activities can help to reduce the spread of HIV infection and tuberculosis and reduce epidemiological tension.

HIV-infection, tuberculosis, comorbidity, anti-tuberculosis therapy, antiretroviral therapy

10.29234/2308-9113-2021-9-3-91-98

1. Ashenova G.Zh., Galkin V.B., Zagdyn Z.M. TB/VICH v Rossijskoj Federacii. Epidemiologiya, osobennosti klinicheskih proyavlenij i rezul'taty lecheniya [TB/HIV in the Russian Federation. Epidemiology, features of clinical manifestations and treatment.] Edited by S.A. Sterlikov. Moscow: RIO CNIIOIZ, 2018. (In Russ.)

2. Viktorova I.B., Nesterenko A.V., Zimina V.N. Koinfekciya (VICH-infekciya/tuberkulez) u beremennyh zhenshchin [Coinfection (HIV/tuberculosis) in pregnant women]. Tuberkulez i bolezni legkih [Tuberculosis and lung disease] 2015; (12): 8-18. (In Russ.)

3. Nechaeva O.B. Monitoring tuberkuleza i VICH-infekcii v Rossijskoj Federacii [Monitoring of tuberculosis and HIV infection in the Russian Federation]. Med. alfavit. Epidemiologiya i gigiena [Med. alphabet. Epidemiology and Hygiene] 2017; (30): 24–33. (In Russ.)

4. Rekomendacii evropejskogo klinicheskogo obshchestva SPIDa. Noyabr' 2019. Russkaya versiya 10.0. [Recommendations of the European AIDS Clinical Society. November 2019. Russian version 10.0.]. Available at: http://hivlife.info/files/HAART/GUIDELINES/EACS­_Guidelines­_v10.0­_RUS.pdf Accessed: 10.19.2021. (In Russ.)

5. Federal'nye klinicheskie rekomendacii po diagnostike i lecheniyu tuberkuleza u zhenshchin vo vremya beremennosti i poslerodovom periode [Federal clinical guidelines for the diagnosis and treatment of tuberculosis in women during pregnancy and the postpartum period] 2014. Available at: http://roftb.ru/netcat­_files/mk/36fb.pdf Accessed: 10.19.2021. (In Russ.)

6. Federal'nye klinicheskie rekomendacii po profilaktike, diagnostike i lecheniyu tuberkulyoza u bol'nyh VICH-infekciej [Federal clinical guidelines for the prevention, diagnosis and treatment of tuberculosis in patients with HIV infection] 2016. Available at: http://roftb.ru/netcat­_files/doks2016/rec2016.pdf Accessed: 10.19.2021. (In Russ.)

7. Federal'nye klinicheskie rekomendacii po tuberkulezu u vzroslyh [Federal clinical guidelines for tuberculosis in adults] 2020. Available at: https://coinfection.net/wp-content/uploads/2020/02/kr-tuberkulez-u-vzroslyh-2020.pdf Accessed: 10.19.2021. (In Russ.)

8. Tsai A.V., Evteev A.V., Podroikin D.V., Sklyanaya E.A. Sovremennye aspekty problemy sochetannyh VICH-infekcii i tuberkuleza [Modern aspects of the problem of combined HIV infection and tuberculosis]. Forcipe 2019; (2): 913. (In Russ.)

9. Chernigovets L.F., Gantsgorn E.V. Epidemiologicheskaya rol' mikrobiologicheskogo i farmakologicheskogo monitoringov v profilaktike infekcij, svyazannyh s okazaniem medicinskoj pomoshchi. [Epidemiological role of microbiological and pharmacological monitoring in the prevention of infections associated with the provision of medical care]. Uspekhi sovremennoj nauki [Advances in modern science] 2017; (7): 166-169. (In Russ.)

10. Chernigovets L.F., Kulak M.A., Berezantseva S.E., Evteev A.V., Goncharenko A.V. Antibiotikorezistentnost' mikrobnoj flory kak faktor riska zdorov'yu naseleniya (na modeli tuberkuleza) [Antibiotic resistance of microbial flora as a risk factor for public health (on the model of tuberculosis)]. Nauchnye osnovy sozdaniya i realizacii sovremennyh tekhnologij zdorov'esberezheniya: VII mezhregional'naya nauchno-prakticheskaya konferenciya (Rostov-na-Donu, 11 dekabrya 2020 g.) [Scientific foundations for the creation and implementation of modern health-preserving technologies: VII interregional scientific and practical conference (Rostov-on-Don, December 11, 2020)]. Volgograd 2020. С. 16-20. (In Russ.)

11. Chandra S., Prithvi P.P.R., Srija K. Antimicrobial resistance: Call for rational antibiotics practice in India. J. Family Med. Prim. Care 2020; 31(9): 2192-2199.

12. LaCourse S.M., Cranmer L.M., Bekker A. Symptom screening for active tuberculosis in pregnant women living with HIV. Cochrane Database Syst Rev 2018; (1): CD012934.

13. Salemi J.L., Salihu H.M. The prevalence of active tuberculosis infection among pregnant women is not increasing in the United States. Am. J. Obstet. Gynecol 2017; 217(4): 490-491.

14. World Health Organization. Global tuberculosis report 2017. Geneva: WHO, 2017. 250 p.

15. Zhang X., Xiao S., Jiang X. Genomic characterization of Escherichia coli CT-EC001, an extremely multidrug-resistant strain with an amazing number of resistance genes. Gut Pathog 2019; (5): 11-25.